"Costco's stock climbed from $844 in December 2025 to over $1,018, reflecting a premium valuation with a trailing P/E of 53x and a forward P/E of 50x."
"In fiscal Q2 2026, Costco posted revenue of $69.60 billion, up 9.22% year over year, with net income rising 13.81% and membership fee income jumping 13.6%."
"Merck's stock climbed from below $83 in early November 2025 to about $124 in March 2026, with a weekly RSI hitting 77 in mid-February 2026."
Costco's stock has risen 18.1% year to date, trading at high P/E ratios, but fundamentals support its premium valuation. Revenue and net income increased significantly, with a strong membership renewal rate. Merck's stock increased 14.8% since the start of the year, showing strong momentum despite a recent pause. The technical indicators for both stocks suggest sustained interest, with Costco's price target above current levels and Merck's valuation affected by a one-time charge.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]